← Back to guidelines
Cardiology121 papers

Nasal polyposis

Last edited: 4/22/2026

Overview

Nasal polyposis refers to benign, non-neoplastic growths originating from the nasal mucosa, often associated with chronic inflammation and obstruction of nasal passages. 1

Diagnosis

  • Key Diagnostic Criteria: Anterior rhinoscopy, endoscopic nasal examination, and coronal paranasal sinus CT scans are essential for diagnosis. 1
  • Recommended Tests: Carotid artery intima-media thickness (CIMT) measurement and flow-mediated vasodilatation (FMD) of the brachial artery can provide additional insights into systemic associations. 1
  • Grading: Endoscopic polyp scores and paranasal sinus CT scores can correlate with severity markers like CIMT and FMD values. 1
  • Management

  • First-Line Treatments: Medical management typically includes corticosteroids (nasal sprays or systemic depending on severity). 1
  • Adjunctive Treatments: Surgical intervention (e.g., endoscopic sinus surgery) may be necessary for persistent or large polyps. 2
  • Monitoring: Regular assessment of CIMT and FMD can help monitor systemic effects and disease progression. 1
  • Special Populations

  • Surgical Considerations: Patients with nasal polyposis undergoing surgery have a higher incidence of mucocele formation, suggesting careful post-operative management. 2
  • Comorbidities: Presence of bronchial asthma or Samter's triad (aspirin sensitivity, asthma, and nasal polyposis) may influence mucocele formation and require tailored treatment approaches. 2
  • Key Recommendations

  • Evaluate patients with nasal polyposis for early atherosclerotic markers such as CIMT and FMD to identify potential systemic risks. (Evidence: Moderate) 1
  • Consider surgical intervention for patients with persistent or large nasal polyps, especially when medical management fails. (Evidence: Expert opinion) 2
  • Monitor for mucocele formation particularly in patients undergoing surgical treatment for nasal polyposis, especially those with a history of trauma or associated conditions like bronchial asthma. (Evidence: Moderate) 2
  • References

    1 Sagit M, Sarli B, Guler S, Namuslu M, Celik HT, Kurtul S et al.. Assessment of early atherosclerotic findings in patients with nasal polyposis. Auris, nasus, larynx 2014. link 2 Chobillon MA, Jankowski R. Relationship between mucoceles, nasal polyposis and nasalisation. Rhinology 2004. link

    Original source

    1. [1]
      Assessment of early atherosclerotic findings in patients with nasal polyposis.Sagit M, Sarli B, Guler S, Namuslu M, Celik HT, Kurtul S et al. Auris, nasus, larynx (2014)
    2. [2]
      Relationship between mucoceles, nasal polyposis and nasalisation.Chobillon MA, Jankowski R Rhinology (2004)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG